Form 4: Artivion CEO Exercises Options, Sells Shares
Insider Transaction Report
Artivion, Inc. President and CEO James P. Mackin exercised stock options and subsequently sold 30,921 shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- James P. Mackin, President & CEO of Artivion, Inc. (AORT), engaged in transactions on December 3, 2025.
- Mackin exercised options to acquire 30,921 shares of common stock at an exercise price of $29.62 per share.
- Immediately following the exercise, Mackin sold 30,921 shares of common stock at a weighted average price of $45.461 per share.
- The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.
- Following these transactions, Mackin beneficially owns 800,993 shares of Artivion, Inc. common stock.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine, pre-planned insider transaction (option exercise and sale) under a 10b5-1 plan, which typically does not indicate a change in company fundamentals or management's view of the company's prospects.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 03/05/2020 | First exercisable date for stock options. |
| 09/02/2025 | Date 10b5-1 trading plan was adopted. |
| 12/03/2025 | Date of stock option exercise and subsequent sale of common stock. |
| 12/04/2025 | Signature date of reporting person. |
| 03/05/2026 | Expiration date for stock options. |
Keywords
Artivion, AORT, James P. Mackin, Insider Trading, Form 4, Stock Options, 10b5-1 Plan, CEO, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.